Citadel Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Citadel Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200	Closed	-$8.43K	–	15466
2023 Q2	$8.43K	Sell	200 -14,400	-99%	-$582K	﹤0.01%	13320
2023 Q1	$520K	Buy	14,600 +13,300	+1,023%	+$483K	﹤0.01%	8220
2022 Q4	$47.7K	Buy	+1,300	New	+$51.4K	﹤0.01%	12200
2022 Q1	–	Sell	-2,800	Closed	-$288K	–	14951
2021 Q4	$288K	Buy	+2,800	New	+$269K	﹤0.01%	11018
2020 Q3	–	Sell	-8,000	Closed	-$466K	–	10951
2020 Q2	$466K	Buy	+8,000	New	+$430K	﹤0.01%	7198
2019 Q2	–	Sell	-38,900	Closed	-$2.01M	–	10045
2019 Q1	$2.01M	Buy	+38,900	New	+$1.89M	﹤0.01%	4449
2018 Q3	–	Sell	-6,700	Closed	-$314K	–	9845
2018 Q2	$314K	Buy	+6,700	New	+$277K	﹤0.01%	7133
2016 Q1	–	Sell	-200	Closed	-$10K	–	8255
2015 Q4	$10K	Buy	+200	New	+$8.9K	﹤0.01%	8284

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's SYNH Position: Q3 2023 in Review

Citadel Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 33,500 shares — an estimated $1.41M sold.

Citadel Advisors first reported a position in SYNH in Q4 2014 and held it in 33 quarters. The position peaked at $139M in Q4 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Citadel Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 33,500 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.41M.
Citadel Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 33 quarters.
Citadel Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $139M in Q4 2020.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.